Sequenom Corp fka SQNM

[martych]

Can't say I like the failed bounce. Now testing soft support so we'll see. The % Williams indicates it's very oversold but that can continue for some time.

I also don't like how much the market seems to like the acquisition from ILMN's perspective. They have bounced almost back to where they were prior to the announcement. That in light of:
- Missed expectations for EPS in C12 (tax credit so minor)
- Dilutive acquisition announced for about 15% of C13 consensus
- Trailing PE of 76x
- Heavy short following
- At least one downgrade with other analysts voicing concern over price and risk of losing significant customer (SQNM about $50m annual revenues)

Never easy with this stock.